vimarsana.com

Latest Breaking News On - Christopher bunick - Page 1 : vimarsana.com

Insights & Outcomes: A carbon removal contest and Cards against tuition

Discussing Risankizumb, Differences in IL-23 Inhibitor Epitopes with Christopher Bunick, MD, PhD

This interview with Bunick featured a discussion of his team’s recent data comparing anti-IL-23 biologics, epitopes, and comparisons with risankizumab.

Study Details Epitope Binding, Efficacy of IL-23 Inhibitors in Plaque Psoriasis

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.